BALDWIN BROTHERS LLC/MA - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 1 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BALDWIN BROTHERS LLC/MA ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q4 2023$696
+8.8%
5610.0%0.00%
Q3 2023$640
+24.8%
5610.0%0.00%
Q2 2023$513
+63.4%
5610.0%0.00%
Q1 2023$314
-3.1%
5610.0%0.00%
Q4 2022$3245610.0%0.00%
Q3 2022$05610.0%0.00%
Q2 2022$05610.0%0.00%
Q1 2022$0
-100.0%
5610.0%0.00%
Q4 2021$1,000
-50.0%
5610.0%0.00%
Q3 2021$2,0000.0%5610.0%0.00%
Q2 2021$2,0000.0%5610.0%0.00%
Q1 2021$2,0000.0%5610.0%0.00%
Q4 2020$2,000
+100.0%
5610.0%0.00%
Q3 2020$1,000
-87.5%
5610.0%0.00%
-100.0%
Q2 2020$8,000
+100.0%
5610.0%0.00%0.0%
Q1 2020$4,000
-50.0%
561
-57.1%
0.00%0.0%
Q4 2019$8,000
+60.0%
1,3090.0%0.00%0.0%
Q3 2019$5,000
-16.7%
1,3090.0%0.00%0.0%
Q2 2019$6,000
-45.5%
1,3090.0%0.00%
-50.0%
Q1 2019$11,000
+37.5%
1,309
-12.5%
0.00%
+100.0%
Q4 2018$8,0001,4960.00%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,031,283$95,485,0005.72%
GREAT POINT PARTNERS LLC 3,510,073$47,667,0003.81%
Logos Global Management LP 1,200,000$16,296,0003.26%
DAFNA Capital Management LLC 762,666$10,357,0002.99%
Baupost Group 15,000,000$203,700,0002.54%
Nantahala Capital Management 6,101,111$82,853,0002.50%
Abrams Capital Management 5,656,462$76,815,0002.48%
Novo Holdings A/S 1,987,506$26,990,0001.74%
Stanley-Laman Group, Ltd. 316,933$4,304,0001.04%
Integral Health Asset Management, LLC 250,000$3,395,0001.02%
View complete list of AKEBIA THERAPEUTICS INC shareholders